MEDNAX, Inc. (MD) CEO Mark Ordan on Q3 2021 Results - Earnings Call Transcript

MEDNAX, Inc. (NYSE:MD) Q3 2021 Earnings Conference Call October 28, 2021 9:00 AM ET

Company Participants

Charles Lynch - Senior Vice President, Finance & Strategy
Mark Ordan - Chief Executive Officer
Marc Richards - Chief Financial Officer
Mack Hinson - President, Pediatrix and Obstetrix Medical Groups
Jim Swift - Executive Vice President Pediatric our Chief Development Officer

Conference Call Participants

Pito Chickering - Deutsche Bank
Kevin Fischbeck - Bank of America
Arianna Brady - BMO Capital Markets
Nick Spiekhout - William Blair
Whit Mayo - SVB Leerink
A.J. Rice - Credit Suisse

Operator

Ladies and gentlemen, thank you for standing by and welcome to the MEDNAX, Inc. Third Quarter 2021 Earnings Conference. At this time, all lines are in a listen-only mode. Later, we will conduct a question-and-answer session. Instructions will be given to you at that time. [Operator Instructions] And as a reminder, today's conference call is being recorded.

I would now like to turn the conference over to Mr. Charles Lynch, Senior Vice President, Finance and Strategy. Please go ahead.

Charles Lynch

Thanks Cynthia. Good morning, everyone. I'll quickly read our forward-looking statements and then we'll get into the call. Certain statements and information during this conference call may be deemed to be forward-looking statements within the meaning of the Federal Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on assumptions and assessments made by MEDNAX's management, in light of their experience and assessment of historical trends, current conditions, expected future developments, and other factors they believe to be appropriate.

Any forward-looking statements made during this call are made as of today, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events, or otherwise.

Important factors that could cause actual results, developments, and business decisions